CIK 0001807120 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Design Therapeutics, Inc.
Sign in to watch- Ticker
- DSGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 823929248
- Phone
- 858-293-4900
- Business address
- 6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD, CA, 92011
- 4 Open-market buy Director bought 21,000 shares at $2.35 ($49,287)
- SC 13G/A Stake Amended Statement of Ownership
- 4/A Open-market buy Director bought 700,000 shares at $20.00 ($14,000,000)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 12,000 shares at $2.31 ($27,670)
- 4 Open-market buy Director bought 2,235,000 shares at an average $2.40 ($5,373,650)
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
Page 7 of 14 · 268 filings